Anthropic partners with six life sciences firms to apply Claude to drug discovery
October 27, 2026
Anthropic is integrating Claude into drug development workflows through research partnerships with organizations including Bristol Myers Squibb and Generate Biomedicines. The focus extends beyond molecular design to target identification, manufacturing optimization, and automating regulatory filing documentation.
HOW THIS AFFECTS YOU
●
founderThis signals a growing competitive landscape for specialized LLM applications in biotech.
●
healthYou can leverage Claude for tasks ranging from molecular design to regulatory drafting.